| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.59 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |